Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.
Gladstone scientists report that they've transformed one kind of human heart cell into another in laboratory experiments, a promising development in the bid to find ways to repair damage from heart attacks.
Researchers from the Gladstone Institutes in San Francisco found that injecting a therapy of genes into dead heart cells has promising implications for restarting the cells, based on studies done in mice and human cells in a lab.
Professor Helps Develop pE-MAP Technique That Allows Scientists To Predict Effect of Enzyme Mutations
A research team led by Nevan Krogan, PhD, of Gladstone Institutes and the University of California, San Francisco (UCSF); Craig Kaplan, PhD, of Texas A&M University; and Christine Guthrie, PhD, a UCSF Professor, has created a new technique called the point mutant E-MAP approach (pE-MAP) to predict how an enzyme behaves, and what happens when this process is disrupted, by mapping thousands of interactions among an enzyme’s many moving parts.
Gladstone Investigator Nevan Krogan, PhD, is named new director of the California Institute for Quantitative Biosciences (QB3).
Gladstone's Warner C. Greene, MD, PhD, explains in an op-ed why we must continue the fight against HIV/AIDS worldwide.
A new type of cell could lead to dramatic cures—and avoid ethical controversy. The Smithsonian's Virginia Hughes speaks to Gladstone stem cell scientist Dr. Deepak Srivastava.
Using a method called optical pulse-labeling (OPL), researchers from the Gladstone Institutes discovered for the first time that neurons’ inability to clear toxic proteins associated with Huntington’s disease is responsible for protein buildup, which eventually causes the neurons to wither away.
Seven years ago, the California stem cell research program was ready to give its very first grants. Voted into law in 2004, it had been delayed by lawsuits from the religious right and anti-tax groups for almost two years. But in 2006, Governor Schwarzenegger authorized a $150 million loan to the fledgling program. Prop 71 author Bob Klein persuaded philanthropists to help as well, and it was time.
Researchers are building upon Shinya Yamanaka's Nobel prize-winning discovery to improve methods of creating iPS cells.